Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancer

Conditions:   Squamous Cell Carcinoma of Head and Neck;   Non-small Cell Lung Cancer;   Hepatocellular Carcinoma;   Esophageal Cancer;   Gastric Cancer;   Melanoma;   Renal Cell Carcinoma;   Pancreatic Cancer;   Cervical Cancer;   Triple Negative Breast Cancer;   Advanced Cancer
Interventions:   Drug: KY1044;   Drug: KY1044 and atezolizumab
Sponsor:   Kymab Limited
Recruiting

http://bit.ly/2D7Dm2g